Invitae Corporation (0JDB.L) LSE

Currency In USD

AD

Invitae Corporation

Address

1400 16th Street

San Francisco, CA 94103

United States of America (the)

Phone

415 374 7782

Sector

Healthcare

Industry

Medical - Pharmaceuticals

Employees

1700

First IPO Date

January 29, 2018

Key Executives

NameTitlePayYear Born
Kenneth D. KnightPresident, Chief Executive Officer & Director1.4M1961
Randal W. ScottCo-Founder & Chairman of the Board50,0001958
Shelly D. GuyerChief Sustainability Officer430,4441960
W. Michael KornChief Medical Officer751,951N/A
Thomas R. BridaGeneral Counsel, Chief Compliance Officer & Secretary776,7221971
David SholehvarChief Operating Officer01968
Ana J. SchrankChief Accounting Officer & Chief Financial Officer01966
Desarie FrenchChief Talent Officer0N/A
Hoki LukHead of Investor Relations and Capital Markets & Corporate Development01976
Robert GuigleyChief Commercial Officer0N/A
AD

Description

Invitae Corporation is a medical genetics enterprise focused on integrating genetic insights into mainstream healthcare to improve patient outcomes across the United States, Canada, and internationally. The company delivers an extensive suite of genetic tests covering diverse clinical domains, including inherited cancers, cardiac health, neurological disorders, pediatric conditions, general oncology, metabolic diseases, and rare illnesses. Beyond testing, they also offer digital health platforms and health data services. Invitae serves a broad customer base, including individual patients, healthcare providers, biopharmaceutical companies, and other collaborators. Established in 2010 as Locus Development, Inc., the company adopted the name Invitae Corporation in 2012 and is headquartered in San Francisco, California.

AD